Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C B Caspar

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The American Journal of Medicine|August 1, 1991
Lactic acidosis in malignant lymphomaC B Caspar, O Oelz
Blood|November 14, 1997
Idiotype vaccines for non-Hodgkin's lymphoma induce polyclonal immune responses that cover mutated tumor idiotypes: comparison of different vaccine formulationsC B Caspar, S Levy, R Levy
Blood|June 1, 1993
Effective stimulation of donors for granulocyte transfusions with recombinant methionyl granulocyte colony-stimulating factorC B Caspar, R A Seger, J Burger, et al.
Schweizerische Medizinische Wochenschrift|January 11, 1994
[3-line response following long-term therapy of severe aplastic anemia using glycosylated rHuG-CSF: dysfunctional thrombocytes as early indication of a myelodysplastic syndrome]C B Caspar, A von Felten, L Widmer, et al.
Blood|February 27, 2001
Idiotype-encoding recombinant adenoviruses provide protective immunity against murine B-cell lymphomasJ M Timmerman, C B Caspar, S L Lambert, et al.
Schweizerische Medizinische Wochenschrift|October 16, 1993
[Alcoholic ketoacidosis]C B Caspar, B Risti, P X Iten, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2008
Renal safety profiles of ibandronate 6 mg infused over 15 and 60 min: a randomized, open-label studyR von Moos, C B Caspar, B Thürlimann, et al.
Blood|May 1, 1997
Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma--long-term results of a clinical trialF J Hsu, C B Caspar, D Czerwinski, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 24, 2001
Idiotype vaccination following ABMT can stimulate specific anti-idiotype immune responses in patients with B-cell lymphomaT A Davis, F J Hsu, C B Caspar, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The American Journal of Medicine|August 1, 1991
Lactic acidosis in malignant lymphomaC B Caspar, O Oelz
Blood|November 14, 1997
Idiotype vaccines for non-Hodgkin's lymphoma induce polyclonal immune responses that cover mutated tumor idiotypes: comparison of different vaccine formulationsC B Caspar, S Levy, R Levy
Blood|June 1, 1993
Effective stimulation of donors for granulocyte transfusions with recombinant methionyl granulocyte colony-stimulating factorC B Caspar, R A Seger, J Burger, et al.
Schweizerische Medizinische Wochenschrift|January 11, 1994
[3-line response following long-term therapy of severe aplastic anemia using glycosylated rHuG-CSF: dysfunctional thrombocytes as early indication of a myelodysplastic syndrome]C B Caspar, A von Felten, L Widmer, et al.
Blood|February 27, 2001
Idiotype-encoding recombinant adenoviruses provide protective immunity against murine B-cell lymphomasJ M Timmerman, C B Caspar, S L Lambert, et al.
Schweizerische Medizinische Wochenschrift|October 16, 1993
[Alcoholic ketoacidosis]C B Caspar, B Risti, P X Iten, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2008
Renal safety profiles of ibandronate 6 mg infused over 15 and 60 min: a randomized, open-label studyR von Moos, C B Caspar, B Thürlimann, et al.
Blood|May 1, 1997
Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma--long-term results of a clinical trialF J Hsu, C B Caspar, D Czerwinski, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 24, 2001
Idiotype vaccination following ABMT can stimulate specific anti-idiotype immune responses in patients with B-cell lymphomaT A Davis, F J Hsu, C B Caspar, et al.
Pageof 1